Selected research
Market Structure
Global Infrapopliteal Artery Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Infrapopliteal Artery Stent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Infrapopliteal Artery Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Infrapopliteal Artery Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Infrapopliteal Artery Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Infrapopliteal Artery Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Infrapopliteal Artery Stent include OrbusNeich Medical Group, Abbott, Shanghai Microport Endovascular Medtech(Group), Acotec Scientific, Wei Qiang (Shanghai) Medical Technology, Medtronic, Leo Medical, Zylox-Tonbridge Medical Technology and Boston Scientific Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Infrapopliteal Artery Stent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Infrapopliteal Artery Stent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Infrapopliteal Artery Stent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Infrapopliteal Artery Stent market size, projected growth trends, production technologies, key applications, and end-use industries.
Infrapopliteal Artery Stent Segment by Company
OrbusNeich Medical Group
Abbott
Shanghai Microport Endovascular Medtech(Group)
Acotec Scientific
Wei Qiang (Shanghai) Medical Technology
Medtronic
Leo Medical
Zylox-Tonbridge Medical Technology
Boston Scientific Corporation
Zhejiang Barty Medical Technology
W.L. Gore & Associates
Terumo
Philips
Cordis Corporation
Cook Medical
Cardio Flow
Becton
BD
Infrapopliteal Artery Stent Segment by Type
Balloon Angioplasty
Stenting
Infrapopliteal Artery Stent Segment by Application
Iliac Artery
Femoral Artery
Other
Infrapopliteal Artery Stent Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infrapopliteal Artery Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Infrapopliteal Artery Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infrapopliteal Artery Stent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Infrapopliteal Artery Stent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infrapopliteal Artery Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Infrapopliteal Artery Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Infrapopliteal Artery Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Balloon Angioplasty
- Stenting
Applications
- Iliac Artery
- Femoral Artery
- Other
Companies covered
- OrbusNeich Medical Group
- Abbott
- Shanghai Microport Endovascular Medtech(Group)
- Acotec Scientific
- Wei Qiang (Shanghai) Medical Technology
- Medtronic
- Leo Medical
- Zylox-Tonbridge Medical Technology
- Boston Scientific Corporation
- Zhejiang Barty Medical Technology
- W.L. Gore & Associates
- Terumo
- Philips
- Cordis Corporation
- Cook Medical
- Cardio Flow
- Becton
- BD
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Infrapopliteal Artery Stent Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Infrapopliteal Artery Stent Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Infrapopliteal Artery Stent Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Infrapopliteal Artery Stent Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Infrapopliteal Artery Stent Market Dynamics
- 2.1 Infrapopliteal Artery Stent Industry Trends
- 2.2 Infrapopliteal Artery Stent Industry Drivers
- 2.3 Infrapopliteal Artery Stent Industry Opportunities and Challenges
- 2.4 Infrapopliteal Artery Stent Industry Restraints
3 Infrapopliteal Artery Stent Market by Manufacturers
- 3.1 Global Infrapopliteal Artery Stent Revenue by Manufacturers (2021-2026)
- 3.2 Global Infrapopliteal Artery Stent Sales by Manufacturers (2021-2026)
- 3.3 Global Infrapopliteal Artery Stent Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Infrapopliteal Artery Stent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Infrapopliteal Artery Stent Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Infrapopliteal Artery Stent Manufacturers, Product Type & Application
- 3.7 Global Infrapopliteal Artery Stent Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Infrapopliteal Artery Stent Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Infrapopliteal Artery Stent Players Market Share by Revenue in 2025
- 3.8.3 2025 Infrapopliteal Artery Stent Tier 1, Tier 2, and Tier 3
4 Infrapopliteal Artery Stent Market by Type
- 4.1 Infrapopliteal Artery Stent Type Introduction
- 4.1.1 Balloon Angioplasty
- 4.1.2 Stenting
- 4.2 Global Infrapopliteal Artery Stent Sales by Type
- 4.2.1 Global Infrapopliteal Artery Stent Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Infrapopliteal Artery Stent Sales by Type (2021-2032)
- 4.2.3 Global Infrapopliteal Artery Stent Sales Market Share by Type (2021-2032)
- 4.3 Global Infrapopliteal Artery Stent Revenue by Type
- 4.3.1 Global Infrapopliteal Artery Stent Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Infrapopliteal Artery Stent Revenue by Type (2021-2032)
- 4.3.3 Global Infrapopliteal Artery Stent Revenue Market Share by Type (2021-2032)
5 Infrapopliteal Artery Stent Market by Application
- 5.1 Infrapopliteal Artery Stent Application Introduction
- 5.1.1 Iliac Artery
- 5.1.2 Femoral Artery
- 5.1.3 Other
- 5.2 Global Infrapopliteal Artery Stent Sales by Application
- 5.2.1 Global Infrapopliteal Artery Stent Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Infrapopliteal Artery Stent Sales by Application (2021-2032)
- 5.2.3 Global Infrapopliteal Artery Stent Sales Market Share by Application (2021-2032)
- 5.3 Global Infrapopliteal Artery Stent Revenue by Application
- 5.3.1 Global Infrapopliteal Artery Stent Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Infrapopliteal Artery Stent Revenue by Application (2021-2032)
- 5.3.3 Global Infrapopliteal Artery Stent Revenue Market Share by Application (2021-2032)
6 Global Infrapopliteal Artery Stent Sales by Region
- 6.1 Global Infrapopliteal Artery Stent Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Infrapopliteal Artery Stent Sales by Region (2021-2032)
- 6.2.1 Global Infrapopliteal Artery Stent Sales by Region (2021-2026)
- 6.2.2 Global Infrapopliteal Artery Stent Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Infrapopliteal Artery Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Infrapopliteal Artery Stent Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Infrapopliteal Artery Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Infrapopliteal Artery Stent Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Infrapopliteal Artery Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Infrapopliteal Artery Stent Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Infrapopliteal Artery Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Infrapopliteal Artery Stent Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Infrapopliteal Artery Stent Revenue by Region
- 7.1 Global Infrapopliteal Artery Stent Revenue by Region
- 7.1.1 Global Infrapopliteal Artery Stent Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Infrapopliteal Artery Stent Revenue by Region (2021-2026)
- 7.1.3 Global Infrapopliteal Artery Stent Revenue by Region (2027-2032)
- 7.1.4 Global Infrapopliteal Artery Stent Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Infrapopliteal Artery Stent Revenue (2021-2032)
- 7.2.2 North America Infrapopliteal Artery Stent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Infrapopliteal Artery Stent Revenue (2021-2032)
- 7.3.2 Europe Infrapopliteal Artery Stent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Infrapopliteal Artery Stent Revenue (2021-2032)
- 7.4.2 Asia-Pacific Infrapopliteal Artery Stent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Infrapopliteal Artery Stent Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Infrapopliteal Artery Stent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 OrbusNeich Medical Group
- 8.1.1 OrbusNeich Medical Group Company Information
- 8.1.2 OrbusNeich Medical Group Business Overview
- 8.1.3 OrbusNeich Medical Group Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 OrbusNeich Medical Group Infrapopliteal Artery Stent Product Portfolio
- 8.1.5 OrbusNeich Medical Group Recent Developments
- 8.2 Abbott
- 8.2.1 Abbott Company Information
- 8.2.2 Abbott Business Overview
- 8.2.3 Abbott Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Abbott Infrapopliteal Artery Stent Product Portfolio
- 8.2.5 Abbott Recent Developments
- 8.3 Shanghai Microport Endovascular Medtech(Group)
- 8.3.1 Shanghai Microport Endovascular Medtech(Group) Company Information
- 8.3.2 Shanghai Microport Endovascular Medtech(Group) Business Overview
- 8.3.3 Shanghai Microport Endovascular Medtech(Group) Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shanghai Microport Endovascular Medtech(Group) Infrapopliteal Artery Stent Product Portfolio
- 8.3.5 Shanghai Microport Endovascular Medtech(Group) Recent Developments
- 8.4 Acotec Scientific
- 8.4.1 Acotec Scientific Company Information
- 8.4.2 Acotec Scientific Business Overview
- 8.4.3 Acotec Scientific Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Acotec Scientific Infrapopliteal Artery Stent Product Portfolio
- 8.4.5 Acotec Scientific Recent Developments
- 8.5 Wei Qiang (Shanghai) Medical Technology
- 8.5.1 Wei Qiang (Shanghai) Medical Technology Company Information
- 8.5.2 Wei Qiang (Shanghai) Medical Technology Business Overview
- 8.5.3 Wei Qiang (Shanghai) Medical Technology Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Wei Qiang (Shanghai) Medical Technology Infrapopliteal Artery Stent Product Portfolio
- 8.5.5 Wei Qiang (Shanghai) Medical Technology Recent Developments
- 8.6 Medtronic
- 8.6.1 Medtronic Company Information
- 8.6.2 Medtronic Business Overview
- 8.6.3 Medtronic Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Medtronic Infrapopliteal Artery Stent Product Portfolio
- 8.6.5 Medtronic Recent Developments
- 8.7 Leo Medical
- 8.7.1 Leo Medical Company Information
- 8.7.2 Leo Medical Business Overview
- 8.7.3 Leo Medical Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Leo Medical Infrapopliteal Artery Stent Product Portfolio
- 8.7.5 Leo Medical Recent Developments
- 8.8 Zylox-Tonbridge Medical Technology
- 8.8.1 Zylox-Tonbridge Medical Technology Company Information
- 8.8.2 Zylox-Tonbridge Medical Technology Business Overview
- 8.8.3 Zylox-Tonbridge Medical Technology Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Zylox-Tonbridge Medical Technology Infrapopliteal Artery Stent Product Portfolio
- 8.8.5 Zylox-Tonbridge Medical Technology Recent Developments
- 8.9 Boston Scientific Corporation
- 8.9.1 Boston Scientific Corporation Company Information
- 8.9.2 Boston Scientific Corporation Business Overview
- 8.9.3 Boston Scientific Corporation Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Boston Scientific Corporation Infrapopliteal Artery Stent Product Portfolio
- 8.9.5 Boston Scientific Corporation Recent Developments
- 8.10 Zhejiang Barty Medical Technology
- 8.10.1 Zhejiang Barty Medical Technology Company Information
- 8.10.2 Zhejiang Barty Medical Technology Business Overview
- 8.10.3 Zhejiang Barty Medical Technology Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Zhejiang Barty Medical Technology Infrapopliteal Artery Stent Product Portfolio
- 8.10.5 Zhejiang Barty Medical Technology Recent Developments
- 8.11 W.L. Gore & Associates
- 8.11.1 W.L. Gore & Associates Company Information
- 8.11.2 W.L. Gore & Associates Business Overview
- 8.11.3 W.L. Gore & Associates Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 W.L. Gore & Associates Infrapopliteal Artery Stent Product Portfolio
- 8.11.5 W.L. Gore & Associates Recent Developments
- 8.12 Terumo
- 8.12.1 Terumo Company Information
- 8.12.2 Terumo Business Overview
- 8.12.3 Terumo Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Terumo Infrapopliteal Artery Stent Product Portfolio
- 8.12.5 Terumo Recent Developments
- 8.13 Philips
- 8.13.1 Philips Company Information
- 8.13.2 Philips Business Overview
- 8.13.3 Philips Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Philips Infrapopliteal Artery Stent Product Portfolio
- 8.13.5 Philips Recent Developments
- 8.14 Cordis Corporation
- 8.14.1 Cordis Corporation Company Information
- 8.14.2 Cordis Corporation Business Overview
- 8.14.3 Cordis Corporation Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Cordis Corporation Infrapopliteal Artery Stent Product Portfolio
- 8.14.5 Cordis Corporation Recent Developments
- 8.15 Cook Medical
- 8.15.1 Cook Medical Company Information
- 8.15.2 Cook Medical Business Overview
- 8.15.3 Cook Medical Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Cook Medical Infrapopliteal Artery Stent Product Portfolio
- 8.15.5 Cook Medical Recent Developments
- 8.16 Cardio Flow
- 8.16.1 Cardio Flow Company Information
- 8.16.2 Cardio Flow Business Overview
- 8.16.3 Cardio Flow Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Cardio Flow Infrapopliteal Artery Stent Product Portfolio
- 8.16.5 Cardio Flow Recent Developments
- 8.17 Becton
- 8.17.1 Becton Company Information
- 8.17.2 Becton Business Overview
- 8.17.3 Becton Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Becton Infrapopliteal Artery Stent Product Portfolio
- 8.17.5 Becton Recent Developments
- 8.18 BD
- 8.18.1 BD Company Information
- 8.18.2 BD Business Overview
- 8.18.3 BD Infrapopliteal Artery Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 BD Infrapopliteal Artery Stent Product Portfolio
- 8.18.5 BD Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Infrapopliteal Artery Stent Value Chain Analysis
- 9.1.1 Infrapopliteal Artery Stent Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Infrapopliteal Artery Stent Production Mode & Process
- 9.2 Infrapopliteal Artery Stent Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Infrapopliteal Artery Stent Distributors
- 9.2.3 Infrapopliteal Artery Stent Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst